First published in Trial Site News.
In March of this year, as part of my investigation into BioNTech’s unusual looking Western Blots (which strongly suggested they falsified key data submitted to the regulators to prove the fidelity of their product), I interviewed Kevin McKernan, a genomics scientist, and R&D lead on the Human Genome Project.
What McKern…